Table 5: Univariate analysis for aGVHD and cGVHD.

Characteristic aGVHD grades 3-4 Extensive cGVHD
Age 0.002* 0.03*
Gender 0.04* 0.2
Cytogenetic at diagnosis 0.6 0.3
Stage of disease before alloSCT 0.8 0.6
RIC Conditioning 0.01a 0.1
GvHD Prophylaxis 0.7 0.05a
Donor age 0.005a 0.01a
Donor gender 0.6 0.9
Transplant, CD34+ 0.4 0.2
WBC engraftment 0.2 0.1
Platelets engraftment 0.9 0.6
Chimerism at day +28 after alloSCT 0.7 0.09
Chimerism at day +56 after alloSCT 0.7 0.5
Chimerism at day +100 after alloSCT 0.06 0.001a
Chimerism at 1 year after alloSCT 0.7 0.3
Chimerism at the end of observation 0.8 0.2

GvHD: Graft Versus Host Disease; aGvHD: Acute GvHD; cGvHD: Chronic GvHD; TRM: Treatment Related Mortality; aSignificant, P value < 0.05.